Michael A. Metzger, President and COO at Syndax Pharmaceuticals Inc (SNDX), sold 72,826 shares at $19.24 ($1.4M) on 2021-09-20, disclosed to the SEC on 2021-09-22.
Open-market sale of $1.4M SNDX by President and COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.24 | 31,455 | $605K | 43.2% |
| 2 | $19.24 | 31,455 | $605K | 43.2% |
| 3 | $19.16 | 4,808 | $92K | 6.6% |
| 4 | $19.16 | 4,808 | $92K | 6.6% |
| 5 | $19.02 | 300 | $6K | 0.4% |
| Total | $19.23 avg | 72,826 |
| $1.4M |
| 100% |
| Filing → |
| SNDX | SELL | 2026-02-10 | $361K | — | Filing → |
| SNDX | SELL | 2026-02-06 | $153K | — | Filing → |
| SNDX | SELL | 2025-09-08 | $5.2M | — | Filing → |